Antitumor Response to a Codon-Optimized HPV-16 E7/HSP70 Fusion Antigen DNA Vaccine
<strong>Background</strong>: Vaccines based on virus-like particles are effective against Human Papilloma Virus (HPV) infection; however, they have not shown a therapeutic effect against HPV-associated diseases. New immunotherapy strategies based on immune responses against tumor antigen...
Main Authors: | Hoorieh Soleimanjahi, Hadi Razavinikoo, Fatemeh Fotouhi, Abdollah Ardebili |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2017-09-01
|
Series: | Iranian Journal of Immunology |
Online Access: | http://iji.sums.ac.ir/article_39308_06a6513856f9ff2890487ea2d125671d.pdf |
Similar Items
-
Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
by: Masoumeh Shirmohammadi, et al.
Published: (2021-01-01) -
Cross-presentation of antigen by HSP70
by: Javid, Babak
Published: (2006) -
Comparison of methylation patterns of E6 gene promoter region in the low-risk and high-risk human papillomavirus
by: Ehsan Zafari, et al.
Published: (2019-02-01) -
Human Papillomavirus Type16- L1 VLP Production in Insect Cells
by: Asghar Abdoli, et al.
Published: (2013-08-01) -
Construction and Evaluation of DNA Vaccine Encoding Fusion Protein of Hepatitis C Virus Core Protein and Hepatitis B Surface Antigen as a Vaccine Candidate
by: Maryam Yazdanian, et al.
Published: (2013-04-01)